United Therapeutics | UTHR - Loan Capital


United Therapeutics reported $100M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Ardelyx USD 202.14M 27.07M Sep/2025
Baxter International USD 9.49B 80M Jun/2025
Bayer EUR 32.71B 1B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.89B 410M Sep/2025
Halozyme Therapeutics USD 800.07M 709.03M Sep/2025
Insmed USD 539.72M 21.23M Sep/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
J&J USD 39.41B 173M Sep/2025
Moderna USD 26M 6M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
PTC Therapeutics USD 1.84B 298.68M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025